search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
MICROPLATE READERS


T


he latest microfabricated tool for neuronal compartmentalisation and co-culture experiments is now being adopted by


laboratories across the world. Its makers believe that that the Omega-96 is the fi rst device of its kind. Modelled on the success of its predecessor, the smaller Omega-4 device, eNuvio quickly realised the potential of a high-throughput screening-compatible version of this versatile neuronal microfl uidic platform. Due to its specialist design and fabrication capabilities, eNuvio is able to create microfl uidic devices with structural features that have very high aspect ratios. T is means that only two wells are needed per experimental unit as opposed to four wells in the case of similar products. T is eff ectively doubles the number of experiments that can be performed per plate. T e Omega-96 fully conforms with


96-well microplate standards, enabling researchers to conduct 48 individual experiments in parallel on a single plate while fully taking advantage of existing automated drug screening infrastructure such as plate hotels, liquid handlers and high content screening systems. T e company anticipates this innovative tool will greatly impact the success and effi ciency of drug discovery and safety toxicology in neurological research areas, particularly in the fi eld of neurodegenerative and neuromuscular diseases. T e Omega series is specifi cally designed to recreate the natural polarity of neurons as they exist in the nervous system. In its most basic application, the device is used to isolate somatic from axonal compartments of neurons thereby off ering researchers a basic experimental platform with increased physiological relevance. T e multiple parallel microchannels that serve to fl uidically isolate each adjoined well pair are large enough to allow neurites or axons to project across into the adjacent well but not the neuronal cell bodies (i.e. somas). Consequently, toxic protein aggregate uptake and transport assays as well as neurotoxicity assays are simple to set up and interpret. Used as a co-culture device, the Omega-96 is an ideal platform to study neurodegenerative diseases, the neuromuscular junction (NMJ), the


eNuvio’s latest platform for neuronal compartmentalisation


VERSATILE NEW TOOL


Fully high-throughput-compatible neuronal compartmentalisation and co-culture microfl uidic platform


nigrostriatal pathway, pain pathways, as well as neuronal chemotaxis.


EASY ACCESS T e open-top well design allows researchers to have direct access to their cultures and can accommodate tissue explants as well as self-assembled 3D cultures (e.g. organoids or spheroids). Maintaining healthy cultures over long periods of time has also never been easier, owing to the evaporation- minimising tracks built into the edge of each Omega-96 plate. T e microplates are available and shipped ready to go: they are sterile, pre-coated and bonded


to high-transmissive glass to ensure microscopy compatibility and superior imaging quality. “T is development opens the door


to more physiologically relevant assays for drug discovery and screening and makes microfl uidics-based neuronal compartmentalisation and co-culture experiments more aff ordable than ever before. We are also creating additional types of microfl uidics microplates, which will be available in the near future, to easily include long-lasting 3D muscle cultures,” explains Hugo McGuire, CEO and co-founder of eNuvio.


www.scientistlive.com 23


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60